UOC
AMED

UBS O'Connor’s Amedisys AMED Stock Holding History

UBS O'Connor’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-474,162
Closed -$46.7M – 284
2025
Q2 		$46.7M Sell
474,162
-343,929
-42% -$32.5M 1.3% 15
2025
Q1 		$75.8M Sell
818,091
-216,721
-21% -$20M 1.79% 15
2024
Q4 		$94M Buy
1,034,812
+534,812
+107% +$49.1M 2.34% 14
2024
Q3 		$48.3M Buy
+500,000
New +$48.8M 1.19% 16

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UBS O'Connor's AMED Position: Q3 2025 in Review

UBS O'Connor sold out of Amedisys (AMED) in Q3 2025, closing a stake of 474,162 shares — an estimated $46.7M sold.

UBS O'Connor first reported a position in AMED in Q3 2024 and held it in 4 quarters. The position peaked at $94M in Q4 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • UBS O'Connor reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 474,162 Amedisys shares in Q3 2025, an estimated $46.7M.
  • UBS O'Connor first reported a position in Amedisys in Q3 2024 and held it in 4 quarters.
  • UBS O'Connor's Amedisys position peaked at $94M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.